• 1. Supramolecularly fine-regulated enantioselective catalysts
  Mónica Vaquero,Laura Rovira,Anton Vidal-Ferran Chem. Commun. 2016 52 11038
• 2. Synthesis of (2S,3S)-[3-2H1]-4-methyleneglutamic acid and (2S,3R)-[2,3-2H2]-4-methyleneglutamic acid
  Petra Dieterich,Douglas W. Young Org. Biomol. Chem. 2006 4 1492
• 3. Comparison of Balanites aegyptiaca parts: metabolome providing insights into plant health benefits and valorization purposes as analyzed using multiplex GC-MS, LC-MS, NMR-based metabolomics, and molecular networking
  Mohamed A. Farag,Mostafa H. Baky,Ibrahim Morgan,Mohamed R. Khalifa,Robert Rennert,Osama G. Mohamed,Magdy M. El-Sayed,Andrea Porzel,Ludger A. Wessjohann,Nehal S. Ramadan RSC Adv. 2023 13 21471
• 4. Chapter 12. Enzyme chemistry
  D. Gani Annu. Rep. Prog. Chem. Sect. B: Org. Chem. 1986 83 303

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Fatty Acyls Branched fatty acids
• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Fatty Acyls Fatty acids and conjugates Branched fatty acids

Recent Advances in the Study of 2-Methyleneglutaric Acid (CAS: 3621-79-2): A Comprehensive Research Brief

2-Methyleneglutaric acid (CAS: 3621-79-2) is a dicarboxylic acid derivative that has garnered significant attention in the field of chemical biology and pharmaceutical research. Recent studies have explored its potential as a versatile intermediate in organic synthesis, as well as its biological activities, including enzyme inhibition and metabolic modulation. This research brief synthesizes the latest findings on 2-Methyleneglutaric acid, focusing on its synthesis, applications, and mechanistic insights.

One of the key advancements in the synthesis of 2-Methyleneglutaric acid involves the use of catalytic asymmetric methods. A 2023 study published in the Journal of Organic Chemistry demonstrated a novel enzymatic approach using engineered ketoreductases to achieve high enantioselectivity in the production of 2-Methyleneglutaric acid derivatives. This method offers a greener alternative to traditional chemical synthesis, reducing the reliance on harsh reagents and improving yield efficiency.

In the realm of biological applications, 2-Methyleneglutaric acid has shown promise as an inhibitor of key metabolic enzymes. Research published in Bioorganic & Medicinal Chemistry Letters highlighted its inhibitory effects on isocitrate lyase (ICL), an enzyme critical for the survival of pathogenic bacteria such as Mycobacterium tuberculosis. These findings suggest potential therapeutic applications for 2-Methyleneglutaric acid in combating antibiotic-resistant infections.

Furthermore, recent investigations into the metabolic pathways involving 2-Methyleneglutaric acid have revealed its role in the tricarboxylic acid (TCA) cycle. A 2024 study in Cell Chemical Biology identified 2-Methyleneglutaric acid as a modulator of mitochondrial function, with implications for diseases linked to metabolic dysregulation, such as cancer and neurodegenerative disorders. The study utilized advanced metabolomics techniques to trace the compound's impact on cellular energy metabolism.

Despite these promising developments, challenges remain in the scalable production and clinical translation of 2-Methyleneglutaric acid. Current research efforts are focused on optimizing synthetic routes and exploring its pharmacokinetic properties. Collaborative initiatives between academia and industry are expected to accelerate progress in this area, paving the way for future therapeutic and industrial applications.

In conclusion, 2-Methyleneglutaric acid (CAS: 3621-79-2) represents a compound of growing importance in chemical biology and pharmaceutical research. Its dual role as a synthetic intermediate and a bioactive molecule underscores its versatility. Continued research will be essential to fully unlock its potential and address existing limitations in production and application.

• 25044-10-4(4-methyl-2-methylidenepentanoic acid)
• 3586-58-1(2-methylidenebutanoic acid)
• 5650-75-9(2-methylidenepentanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)